Compare W W Grainger Inc (GWW) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
W W Grainger Inc vs UnitedHealth Group Inc — how do they compare? W W Grainger Inc trades at $1,400.73 (market cap $64.75B), while UnitedHealth Group Inc trades at $433.93 (market cap $380.08B). The key difference: UnitedHealth Group Inc is far larger — about 5.9× W W Grainger Inc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.22%). Which is the better fit depends on your goals.
| GWW | UNH | |
|---|---|---|
Market Cap | $64.75B | $380.08B |
Sector | Technology | Health |
52-Week High | $1.39K | $431.68 |
52-Week Low | $918.18 | $237.77 |
Enterprise Value | $66.84B | $426.76B |
Dividend Yield | 0.68% | 2.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GWW trades at $1,398.30, up 1.99% on the day, with a bullish technical outlook supported by moving averages and strong momentum indicators. The company reported robust Q1 2026 earnings of $11.65 per share, beating estimates, and raised its full-year guidance. Revenue growth and profitability remain solid, with a net income margin of 9.7% and ROE of 48.1% for 2025. Recent news highlights its inclusion in high-quality dividend and momentum stock lists, reflecting positive market recognition.
The outlook for GWW is positive, driven by earnings beats and upward guidance revisions, though valuation multiples like a P/E of 36.88 suggest premium pricing. Risks include competitive pressures in the industrial services sector and reliance on MRO market demand. Analyst consensus is cautious with a hold-heavy rating, but the average price target of $1,260 implies modest upside potential from current levels.
UnitedHealth Group (UNH) trades at $425.19, down 0.91% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with revenue growth to $447.57B in 2025 and consistent earnings beats, though net margins have compressed. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
Outlook remains positive with an 82.69% analyst buy rating and $438.33 consensus target, but risks include regulatory lawsuits and debt levels. The aging U.S. population and tech investments provide growth tailwinds, yet investors should monitor margin pressures and legal challenges from state Medicaid suits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
